The lower expression of sestrin 2 was associated with advanced tumor stage, lymphatic and vascular invasion, liver metastasis, shorter disease-free and overall survival [30], upper eyelid involvement in sebaceous gland carcinoma [34], and radiosensitization [37]. Here, SESN2 is linked to sebaceous adenocarcinoma.